Real-world evidence in advertising CONTEXT: A very interesting opinion piece on the implications of the increased role of real-world evidence (RWE) in the pharmaceutical industry. The article lays out the Continue Reading
Cures 2.0 – Details of what’s in store for Real-World Evidence CONTEXT: This article provides a nice summary and a bit more detail on the draft legislation that will eventually Continue Reading
Are decentralised trials here to stay? Who knows…. CONTEXT: This is an opinion piece from Veradigm® asking whether decentralised trials will live on beyond the pandemic and as they have Continue Reading
French researchers first exposure to decentralised trials CONTEXT: Discussion article on one French company’s first experience with the concept of decentralised clinical trials and how they went about solving the Continue Reading
Medidata’s Acorn AI Synthetic Control Arm (SCA) awarded Best AI-based Solution for Healthcare. CONTEXT: Medidata’s Acorn AI Synthetic Control Arm (SCA) takes Best AI-based Solution for Healthcare at this years Continue Reading
Big Data just got bigger as HealthVerity set to grow real-world data platform CONTEXT: Commercial announcement by HealthVerity as they close their series D funding round adding $100million to directly fund the Continue Reading
Decentralised Trials here to stay, but maybe not as many as we think. CONTEXT: A new report from Science 37 (a provider of Decentralised Clinical Trial (DCT) Software) based on Continue Reading
CONTEXT: Commercial announcement from PCM trials of the opening of a London office to better serve their decentralised trial offering in Europe. IMPACT: Low READ TIME: 1 min Quality Level Continue Reading
CONTEXT: Commercial announcement – Syneos expands its decentralised trial offering IMPACT: Low READ TIME: 1 min Quality Level Mean [1 – 10]: 3 ” TRIALS & FILINGS Novavax COVID-19 Vax Continue Reading
CONTEXT: Opinion piece on decentralised trials. Interesting timing ahead of the DIA making the topic a major platform for this year’s get together. IMPACT: Low READ TIME: 2 mins Continue Reading
